Economic impact and chronic obstructive pulmonary disease outcomes of a comprehensive inhaler to nebulization therapy protocol implementation in a large multi-state healthcare system
Author:
Affiliation:
1. Banner Desert Medical Center, Banner Health, Mesa, AZ, USA
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://tandfonline.com/doi/pdf/10.1080/03007995.2019.1628562
Reference50 articles.
1. NORC at the University of Chicago. Final report: trends in hospital inpatient drug costs: issues and challenges [Internet]. 2016 [cited 2018 Dec 7]. Available from: https://www.aha.org/system/files/2018-01/aha-fah-rx-report.pdf
2. GoodRx: here’s why asthma inhalers are so expensive [Internet]. [cited 2019 Jan 31]. Available from: https://www.goodrx.com/blog/heres-why-asthma-inhalers-are-so-expensive/
3. Hospital Discharges, Readmissions, and ED Visits for COPD or Bronchiectasis Among US Adults
4. Trends in Outcomes, Financial Burden, and Mortality for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) in the United States from 2002 to 2010
5. Inhaler Use in Hospitalized Patients with Chronic Obstructive Pulmonary Disease or Asthma: Assessment of Wasted Doses
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Estimating Tiotropium Wasted Doses After Adding Revefenacin to an Inpatient Formulary: A Single-Center Cross-Sectional Study;Hospital Pharmacy;2024-01-04
2. Economic and workload impact of therapeutic interchange of inhaler medications and nebulizer solutions;American Journal of Health-System Pharmacy;2020-10-26
3. Systemic Steroid and Nebulized Budesonide Combination Therapy Versus Systemic Steroid Monotherapy in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in a Community Hospital: A Retrospective Cohort Study;Hospital Pharmacy;2020-10-20
4. Nebulized Therapies in COPD: Past, Present, and the Future;International Journal of Chronic Obstructive Pulmonary Disease;2020-07
Nebulized Therapies in COPD: Past, Present, and the Future
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3